Avantor Enhances U.S. Biomanufacturing Infrastructure with Expanded Testing Capabilities
Avantor announced the expansion of its St. Louis facility to include advanced microbial and stability testing, strengthening its U.S. biomanufacturing support infrastructure. The upgrade localizes testing that was previously handled across third-party labs and global networks, enabling faster turnaround times, improved data visibility, and reduced supply chain complexity. By consolidating these capabilities into one North American site, Avantor aims to accelerate product development timelines while maintaining high regulatory and quality standards for biopharma customers. 
Avantor Enhances U.S. Biomanufacturing Infrastructure with Expanded Testing Capabilities